These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8981951)

  • 21. Expression of the cystic fibrosis transmembrane conductance regulator (CFTR) mRNA in normal and pathological adult human epididymis.
    Patrizio P; Salameh WA
    J Reprod Fertil Suppl; 1998; 53():261-70. PubMed ID: 10645285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the cystic fibrosis transmembrane conductance regulator gene in the respiratory tract of normal individuals and individuals with cystic fibrosis.
    Trapnell BC; Chu CS; Paakko PK; Banks TC; Yoshimura K; Ferrans VJ; Chernick MS; Crystal RG
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6565-9. PubMed ID: 1713683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The molecular basis for disease variability in cystic fibrosis.
    Kerem B; Kerem E
    Eur J Hum Genet; 1996; 4(2):65-73. PubMed ID: 8744024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcript analysis of CFTR nonsense mutations in lymphocytes and nasal epithelial cells from cystic fibrosis patients.
    Will K; Dörk T; Stuhrmann M; von der Hardt H; Ellemunter H; Tümmler B; Schmidtke J
    Hum Mutat; 1995; 5(3):210-20. PubMed ID: 7541274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular study of (TG)m(T)n polymorphisms in Iranian males with congenital bilateral absence of the vas deferens.
    Radpour R; Gourabi H; Gilani MA; Dizaj AV
    J Androl; 2007; 28(4):541-7. PubMed ID: 17314234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Homozygous 5T alleles, clinical presentation and genetic analysis within a family with congenital bilateral absence of the vas deferens].
    Feng JR; Zhang YN; Wu X; Yang XJ; Chen ST; Ma GC; Luo SG; Zhang Y
    Zhonghua Yi Xue Za Zhi; 2018 May; 98(18):1414-1418. PubMed ID: 29804404
    [No Abstract]   [Full Text] [Related]  

  • 27. Identification of a splice site mutation (2789 +5 G > A) associated with small amounts of normal CFTR mRNA and mild cystic fibrosis.
    Highsmith WE; Burch LH; Zhou Z; Olsen JC; Strong TV; Smith T; Friedman KJ; Silverman LM; Boucher RC; Collins FS; Knowles MR
    Hum Mutat; 1997; 9(4):332-8. PubMed ID: 9101293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cystic fibrosis patients with the 3272-26A-->G mutation have mild disease, leaky alternative mRNA splicing, and CFTR protein at the cell membrane.
    Beck S; Penque D; Garcia S; Gomes A; Farinha C; Mata L; Gulbenkian S; Gil-Ferreira K; Duarte A; Pacheco P; Barreto C; Lopes B; Cavaco J; Lavinha J; Amaral MD
    Hum Mutat; 1999; 14(2):133-44. PubMed ID: 10425036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis.
    Cohn JA; Friedman KJ; Noone PG; Knowles MR; Silverman LM; Jowell PS
    N Engl J Med; 1998 Sep; 339(10):653-8. PubMed ID: 9725922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations in the cystic fibrosis gene in men with congenital bilateral absence of the vas deferens.
    De Braekeleer M; Férec C
    Mol Hum Reprod; 1996 Sep; 2(9):669-77. PubMed ID: 9239681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA.
    Chu CS; Trapnell BC; Curristin S; Cutting GR; Crystal RG
    Nat Genet; 1993 Feb; 3(2):151-6. PubMed ID: 7684646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis.
    Hamosh A; Trapnell BC; Zeitlin PL; Montrose-Rafizadeh C; Rosenstein BJ; Crystal RG; Cutting GR
    J Clin Invest; 1991 Dec; 88(6):1880-5. PubMed ID: 1721624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variable levels of normal RNA in different fetal organs carrying a cystic fibrosis transmembrane conductance regulator splicing mutation.
    Chiba-Falek O; Parad RB; Kerem E; Kerem B
    Am J Respir Crit Care Med; 1999 Jun; 159(6):1998-2002. PubMed ID: 10351951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations of the CFTR gene in Turkish patients with congenital bilateral absence of the vas deferens.
    Dayangaç D; Erdem H; Yilmaz E; Sahin A; Sohn C; Ozgüç M; Dörk T
    Hum Reprod; 2004 May; 19(5):1094-100. PubMed ID: 15070876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variable deletion of exon 9 coding sequences in cystic fibrosis transmembrane conductance regulator gene mRNA transcripts in normal bronchial epithelium.
    Chu CS; Trapnell BC; Murtagh JJ; Moss J; Dalemans W; Jallat S; Mercenier A; Pavirani A; Lecocq JP; Cutting GR
    EMBO J; 1991 Jun; 10(6):1355-63. PubMed ID: 1709095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Splicing modulation as a modifier of the CFTR function.
    Nissim-Rafinia M; Kerem B
    Prog Mol Subcell Biol; 2006; 44():233-54. PubMed ID: 17076271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extensive posttranscriptional deletion of the coding sequences for part of nucleotide-binding fold 1 in respiratory epithelial mRNA transcripts of the cystic fibrosis transmembrane conductance regulator gene is not associated with the clinical manifestations of cystic fibrosis.
    Chu CS; Trapnell BC; Curristin SM; Cutting GR; Crystal RG
    J Clin Invest; 1992 Sep; 90(3):785-90. PubMed ID: 1381723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel cause of hereditary obstructive azoospermia: a T2 allele in the CFTR gene.
    Radpour R; Taherzadeh-Fard E; Gourabi H; Aslani S; Vosough Dizaj A; Aslani A
    Reprod Biomed Online; 2009 Mar; 18(3):327-32. PubMed ID: 19298730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cystic fibrosis mutation screening in CBAVD patients and men with obstructive azoospermia or severe oligozoospermia.
    Kanavakis E; Tzetis M; Antoniadi T; Pistofidis G; Milligos S; Kattamis C
    Mol Hum Reprod; 1998 Apr; 4(4):333-7. PubMed ID: 9620832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variation in a repeat sequence determines whether a common variant of the cystic fibrosis transmembrane conductance regulator gene is pathogenic or benign.
    Groman JD; Hefferon TW; Casals T; Bassas L; Estivill X; Des Georges M; Guittard C; Koudova M; Fallin MD; Nemeth K; Fekete G; Kadasi L; Friedman K; Schwarz M; Bombieri C; Pignatti PF; Kanavakis E; Tzetis M; Schwartz M; Novelli G; D'Apice MR; Sobczynska-Tomaszewska A; Bal J; Stuhrmann M; Macek M; Claustres M; Cutting GR
    Am J Hum Genet; 2004 Jan; 74(1):176-9. PubMed ID: 14685937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.